Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effect of Magnesium Oxide or Citrate Supplements on Metabolic Risk Factors in Kidney Stone Formers With Idiopathic Hyperoxaluria: A Randomized Clinical Trial Publisher Pubmed



Taheri M1 ; Jalali S2 ; Borumandnia N1 ; Tavasoli S1 ; Basiri A1 ; Taheri F3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. University of British Columbia, Vancouver, BC, Canada
  3. 3. Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran

Source: Magnesium Research Published:2024


Abstract

Magnesium is one of the recommended treatments for calcium stone formers (CSFs) with hyperoxaluria. In this study, we compared the effect of magnesium oxide (MgO) or magnesium citrate (MgCit) with placebo on 24-hour urine (24-U) metabolites and the calcium oxalate supersaturation index (CaOx SS). Methods: In a randomized, double-blind, placebo-controlled clinical trial, 90 CSFs with idiopathic hyperoxaluria were recruited from a tertiary stone prevention clinic. Patients were randomly assigned into three groups: 120 mg MgO, 120 mg MgCit or placebo (supplements were taken three times per day, with meals). Finally, 76 patients were included in the final analysis. Analyses of 24-U were performed at baseline and after eight weeks. Study outcomes included changes in 24-U oxalate, magnesium, citrate, and CaOx SS. Dietary factors were controlled by 24-hour food recalls. Repeated measure ANOVA was used to compare the results. Results: After the intervention, both MgO and MgCit supplements decreased 24-U oxalate excretion (-8.13±16.45 in the MgO group and-16.99±18.02 in the MgCit group) and CaOx SS compared to the placebo, with the effects of MgCit reaching statistical significance (p=0.011 and p=0.010, respectively). An increasing trend was observed for 24-U magnesium and citrate excretion without significant differences among groups. Interest-ingly, MgCit exhibited a significantly greater inhibitory effect on 24-U oxalate in patients with normal urine magnesium levels (p=0.021). Conclusions: Clin-ically, both MgO and MgCit reduced 24-U oxalate and CaOx SS compared to placebo. However, MgCit demonstrated a greater effect, especially in patients with normal urine magnesium levels. © 2024, John Libbey. All rights reserved.
Related Docs
1. Evaluating the Associations Between Urinary Excretion of Magnesium and That of Other Components in Calcium Stone-Forming Patients, International Urology and Nephrology (2019)
2. The Tolerability of Potassium Citrate Tablet in Patients With Intolerance to Potassium Citrate Powder, Urology Journal (2018)
3. The Tolerability of Potassium Citrate Tablet in Patients With Intolerance to Potassium Citrate Powder, Urology Journal (2018)
4. Preventive Kidney Stones: Continue Medical Education, International Journal of Preventive Medicine (2017)
5. Dietary Plants for the Prevention and Management of Kidney Stones: Preclinical and Clinical Evidence and Molecular Mechanisms, International Journal of Molecular Sciences (2018)
Experts (# of related papers)
Roja Rahimi (1)
Mastaneh Moghtaderi (1)